None of the pharmaceutical companies involved in the manufacture of Covid-19 vaccines has applied to SA’s medicines regulator for registration, an essential first step to their use.

Helen Rees, chair of the SA Health Products Regulatory Authority (Sahpra), said in an interview on Tuesday that only Johnson & Johnson (J&J) had taken the first steps to registration by submitting a “rolling application”, in which data was provided as it became available. However, J&J has not yet got its final results from phase 3 trials, which are expected later in January...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.